drugset / Trial / NCT04188015
Study of ANX007 in Participants With Primary Open-angle Glaucoma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a double-masked, randomized, sham-controlled study evaluating two dose levels of ANX007 vs sham, administered as repeat Intravitreal (IVT) injections in patients with Primary Open-angle Glaucoma.
Timeline
- Start
- 2018-07-25
- Primary completion
- 2019-06-03
- Completion
- 2019-06-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ANX007 | Unknown | 2.5 mg | Intravitreal |
| Subject | ANX007 | Unknown | 5 mg | Intravitreal |